Affymetrix, ParAllele Bioscience, Roche, Epigenomics, TheRyte, Scottish Enterprise, European Regional Development Funds, Cornell, GenVault, Michigan Life Sciences | GenomeWeb

Affymetrix Announces ParAllele Bioscience Deal

In a three-year non-exclusive agreement announced last week, Affymetrix will supply GeneChip Tag arrays for ParAllele Bioscience of South San Francisco to use in its assay technology for SNP genotyping.

Affymetrix will supply catalog and custom-designed arrays for ParAllele to use in its commercial genotyping services. And, the two companies will enter a R&D agreement using GeneChip arrays to develop SNP assays. Financial terms were not disclosed.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.